Resultats globals: 3 registres trobats en 0.03 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
9 p, 634.6 KB Bullseye's representation of cerebral white matter hyperintensities / Sudre, Carol H. (Dementia Research Centre, UCL Institute of Neurology, WC1N 3BG London, UK) ; Gómez-Ansón, Beatriz (Institut d'Investigació Biomèdica Sant Pau) ; Davagnanam, Indran (University College London. Institute of Neurology) ; Schmitt, Anne Jutta (Lysholm Department of Neuroradiology, The National Hospital for Neurology and Neurosurgery, Queen Square, WCN1 3BG London, UK) ; Mendelson, Alex F. (Translational Imaging Group, University College London, UK) ; Prados Carrasco, Ferran (Translational Imaging Group, CMIC, University College London, UK) ; Smith, Lorna (Institute of Cardiovascular Science (Londres, Regne Unit)) ; Atkinson, David (University College London. Centre for Medical Image) ; Hughes, Alun D. (Institute of Cardiovascular Science (Londres, Regne Unit)) ; Chaturvedi, Nish R. (Institute of Cardiovascular Science (Londres, Regne Unit)) ; Cardoso, jorge Jorge (Dementia Research Centre, UCL Institute of Neurology, London, UK) ; Barkhof, Frederik (University College London. Institute of Neurology) ; Rolf Jaeger, H. (University College London. Institute of Neurology) ; Ourselin, Sebastien (Dementia Research Centre, UCL Institute of Neurology, London, UK) ; Universitat Autònoma de Barcelona
Visual rating scales have limited capacities to depict the regional distribution of cerebral white matter hyperintensities (WMH). We present a regional-zonal volumetric analysis alongside a visualization tool to compare and deconstruct visual rating scales. [...]
2018 - 10.1016/j.neurad.2017.10.001
Journal of Neuroradiology. Journal De Neuroradiologie, Vol. 45 (march 2018) , p. 114-122  
2.
7 p, 303.7 KB Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer / Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; López Vilaró, Laura (Institut d'Investigació Biomèdica Sant Pau) ; Pérez Olabarria, Maitane (Institut d'Investigació Biomèdica Sant Pau) ; Vázquez, Tania (Institut d'Investigació Biomèdica Sant Pau) ; Pons, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Gich, Ignasi (Institut d'Investigació Biomèdica Sant Pau) ; Alonso, Carmen (Institut d'Investigació Biomèdica Sant Pau) ; Ojeda, Belén (Institut d'Investigació Biomèdica Sant Pau) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Lerma Puertas, Enrique (Institut d'Investigació Biomèdica Sant Pau) ; Barnadas i Molins, Agustí (Institut d'Investigació Biomèdica Sant Pau) ; Escuin i Borràs, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Human epidermal growth factor receptor 2 (HER2) and topoisomerase II alpha (TOP2A) genes have been proposed as predictive biomarkers of sensitivity to anthracycline chemotherapy. Recently, chromosome 17 centromere enumeration probe (CEP17) duplication has also been associated with increased responsiveness to anthracyclines. [...]
2014 - 10.1016/j.neo.2014.08.012
Neoplasia (New York, N.Y.), Vol. 16 (october 2014) , p. 861-867  
3.
7 p, 412.7 KB Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease : A Fabry Outcome Survey analysis / Beck, Michael (University Medical Center, University of Mainz, Department of Paediatrics) ; Hughes, Derralynn A (Royal Free London NHS Foundation Trust, University College of London) ; Kampmann, Christoph (University Medical Center, University of Mainz, Department of Paediatrics) ; Larroque, Sylvain (Shire, Zug) ; Mehta, Atul (Royal Free London NHS Foundation Trust, University College of London) ; Pintos-Morellell, Guillem (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ramaswami, Uma (Royal Free London NHS Foundation Trust, University College of London) ; West, Michael (Department of Medicine, Dalhousie University) ; Wijatyk, Anna (Shire) ; Giugliani, Roberto (Medical Genetics Service HCPA/Dep Genet UFRGS and INAGEMP, Porto Alegre) ; Universitat Autònoma de Barcelona
Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. [...]
2015 - 10.1016/j.ymgmr.2015.02.002
Molecular Genetics and Metabolism Reports, Vol. 3 (march 2015) , p. 21-27  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.